Abstract
The term ‘renal bone disease’ or ‘renal osteodystrophy’ is used to describe osseous disorders occurring in patients with renal disease21,33,43,49,53,71. Abnormalities of bone are seen mainly in patients suffering from chronic renal failure (impaired glomerular filtration rate, GFR). Variants of metabolic bone disease may also occur in patients with a normal GFR, but with renal tubular acidosis, nephrotic syndrome, renal stone diseases and oxalosis. A wide spectrum of factors influences the skeleton in renal disorders: the type of renal disease, the degree of uraemia, the severity of secondary hyperparathyroidism, changes in vitamin D metabolism, accumulation of toxic products (e.g. aluminium, fluorine, iron)11,51,68,70, the type and duration of dialysis therapy and of drugs, particularly corticosteroids5,21,25,26,37,38,50. Patients with renal disease are also subject to the same conditions that affect the skeleton in normal individuals: sex, age, activity, endocrine disturbances, ethanol intake, immobilization, diabetes mellitus5 and so forth. For example, renal complications may occur in B-cell dyscrasias due to deposition of monoclonal immunoglobulins in the kidneys34.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
References
Andress D. L., Kopp J. B., Maloney N. A., Coburn J. W. and Sherrard D. J. (1987). Early deposition of aluminium in bone in diabetic patients on haemodialysis. N. Engl. J. Med., 316, 292
Andress D. L., Maloney N. A., Endres D. B. and Sherrard D. J. (1986). Aluminium-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. J. Bone Miner. Res., 1, 391
Andress D. L., Maloney N. A., Coburn J. W., Endress D. B. and Sherrard D. J. (1987). Osteomalacia and aplastic bone disease in aluminium-related osteodystrophy. J. Clin. Endocrinol. Metab., 65, 11
Andress D. L., Nebeker H. G. and Ott S. M. (1987). Bone histologic response to long-term treatment with deferoxamine for aluminium-related bone disease. Kidney Int., 31, 1344
Andress D. L., Pandian M. R., Endres D. B. and Kopp J. B. (1989). Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidism. Kidney Int., 36, 471
Asai K., Miura S., Kawahara H., Toriyama T. and Kuzuya F. (1991). A comparative study of atherosclerosis and osteopenia in elderly and young hemodialysis patients. Aging (Milano), 3, 79
Avram M. M. (1980). Lower parathyroid hormone and creatinine in diabetic uremia. Contrib. Nephrol., 20, 4
Blumenthal N. C. and Posner A. S. (1984). In vitro model of aluminium-induced osteomalacia: inhibition of hydroxyapatite formation and growth. Calcif. Tissue Int., 36, 439
Bone J. M., Davison A. M. and Robson J. S. (1972). The role of dialysate calcium concentration in osteoporosis in patients on hemodialysis. Lancet, 1, 1047
Bouillon R., Verberckmoes R. and DeMoor P. (1975). Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis. Kidney Int., 7, 422
Boyce B. F., Fell G. S. and Elder H. Y. (1982). Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet, 2, 1009
Burnell J. M., Teubner E., Wegedal J. E. and Sherrard D. J. (1974). Bone crystal maturation in renal osteodystrophy in humans. J. Clin. Invest., 53, 52
Carroll R. N. P., Williams E. D., Aung T., Yeboah E. and Shackman R. (1973). The effects of renal transplantation on renal osteodystrophy. Proc. Europ. Dialysis Transpl. Assoc., 10, 446
Casey T., Stone W. J., DiRaimondo C. R., Brantley B. D., DiRaimondo C. V., Gorevic P. D. and Page D. L. (1986). Tumoral amyloidosis of bone of beta-2-microglobulin origin associated with long term hemodialysis: a new type of amyloid disease. Hum. Pathol., 17, 731
Cassidy M. J. D., Owen J. P. and Ellis H. A. (1985). Renal osteodystrophy and metastatic calcification on long-term continuous ambulatory peritoneal dialysis. Q. J. Med., 54, 29
Chan Y., Furlong T. J., Cornish C. J. and Posen S. (1985). Dialysis osteodystrophy. A study involving 94 patients. Medicine, 64, 296
Charhon S. A., Berland Y F. and Olmer M. J. (1985). Effects of parathyroidectomy on bone formation and mineralisation in hemodialysed patients. Kidney Int., 27, 426
Charhon S. A., Chavassieux P. and Boivin G. (1987). Desferrioxamine-induced bone changes in haemodialysis patients: a histomorphometric study. Clin. Sci., 73, 227
Charhon S. A., Chavassieux P. M., Chapuy M. C., Boivin G. Y. and Meunier P. J. (1985). Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminium intoxication. J. Lab. Clin. Med., 106, 123
Charhon S. A., Delmas P. D. and Malaval L. (1986). Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. J. Clin. Endocrinol. Metab., 63, 892
Coburn J. W. and Slatopolsky E. (1991). The renal osteodystrophies. Brenner B. M. and Rector F. C., The Kidney, 4th edn (p. 2057). Philadelphia: Saunders
Connor M. O., Garrett P., Dockery M., Donohoe J. F., Doyle G. D., Carmody M. and Dervan P. A. (1986). Aluminium-related bone disease: correlation between symptoms, osteoid volume and aluminium staining. Amer. J. Clin. Pathol., 86, 168
Cournot-Witmer G., Plachot J. J. and Bourdeau A. (1986). Effect of aluminium on bone and cell localization. Kidney Int, 29(Suppl. 18), 37
Cournot-Witmer G., Zingraff J. and Plachot J. J. (1981). Aluminium localization in bone from haemodialyzed patients: relationship to matrix mineralisation. Kidney Int., 20, 375
Cundy T., Hamdy N., Gray R., Jackson B. and Kanis J. A. (1985). Hyperparathyroid bone disease in chronic renal failure. Ulster Med. J., 54, s34
Cundy T., Hand D. J. and Oliver D. O. (1985). Who gets renal bone disease before beginning dialysis? Brit. Med. J., 290, 271
Dalen N. and Alvestrand A. (1973). Bone mineral content in chronic renal failure and after renal transplantation. Clin. Nephrol., 1, 338
Denton F., Freemont A. J. and Ball J. (1984). Detection and distribution of aluminium in bone. J. Clin. Pathol., 37, 136
DiRaimondo C. R., Casey T. T., DiRaimondo C. V. and Stone W. J. (1986). Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron, 43, 22
Editorials. (1991). Dialysis amyloidosis. Lancet, 338, 349
Ellis H. A. and Peart K. M. (1973). Azotemic renal osteodystrophy, a quantitative study on iliac. J. Clin. Pathol., 26, 83
Ellis H. A., Pierides A. M., Feest T. G., Ward M. K. and Kerr D. N. S. (1977). Histopathology of renal osteodystrophy with particular reference to the effects of 1 alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis. Clin. Endocrinol, 7(Suppl.), 31
Feest T. G., Ward M. K., Ellis, H. A., Conceicao S., Pierides A. M., Aird E., Simpson W., Cook D. B. and Kerr D. N. S. (1977). Renal bone disease -what is it and why does it happen? Clin. Endocrinol., 7(Suppl.), 19
Gallo G. (1991). Renal complications of B-cell dyscrasias. N. Engl. J. Med., 324, 1889
Gejyo F., Yamada T. and Odani S. (1985). A new form of amyloid protein associated with chronic hemodialysis was identified as /32- microglobulin. Biochem. Biophys. Res. Commun., 129, 701
Gilmour J., Wu G., Khanna R., Schilling H., Mitwalli A. and Oreopoulos D. G. (1985). Long-term continuous ambulatory peritoneal dialysis. Peritonea/ Dial. Bull., 5, 112
Grech P., Martin T. J., Barrington N. A. and Ell P. J. (1985). Diagnosis of Metabolic Bone Disease London: Chapman & Hall
Hodgson S. F. (1986). Skeletal remodeling and renal osteodystrophy. Semin. Nephrol., 6, 42
Hutchinson A. J., Freemont A. J., Lumb G. A. and Gokal R. (1991). Renal osteodystrophy in CAPD. Adv. Peritoneal Dial., 7, 237
Joffe P., Podenphant J. and Haef J. G. (1989). Bone histology in CAPD patients: a comparison with haemodialysis and conservatively treated chronic uremics. Adv. Peritoneal Dial., 5, 171
Kachel H. G., Altmeyer P., Baldamus C. A. and Koch K. M. (1983). Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment. Contrib. Nephrol., 36, 127
Kanis J. A. (1987). Clodronate - a new perspective in the treatment of neoplastic bone disease. Bone, 8(Suppl. 1), 1
Kanis J. A., Cundy T. and Hamdy N. A. T. (1988). Renal osteodystrophy. Clin. Endocrinol Metab., 2(1), 193
Kerr D. N. S., Walls J. and Ellis H. (1969). Bone disease in patients undergoing regular haemodialysis. J. Bone Jt Surg., 51 B, 578
Kleinman K. S. and Coburn J. W. (1989). Amyloid syndromes associated with hemodialysis. Kidney Int., 25, 567
Kriegshauser J. S., Swee R. G., McCarthy J. T. and Hauser M. F. (1987). Aluminium toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results. Radiology, 164, 399
Kurer M. H. J., Baillod R. A. and Madgwick J. C. A. (1991). Musculoskeletal manifestations of amyloidosis: a review of 83 patients on haemodialysis for at least 10 years. J. Bone Jt Surg., 73B, 271
Linke R. P., Nathrath W. B. J. and Eulitz M. (1986). Classification of amyloid syndromes from tissue sections using antibodies against various amyloid fibril proteins: report of 142 cases. Glenner G. G., Osserman E. F., Benditt E. P., Calkins E., Cohen A. S. and Zucker-Franklin D., Amyloidosis New York: Plenum
Llack F. (1991). Renal bone disease. Transplant Proc., 23, 1818
Lopez-Hilker S., Galceran T. and Chan Y. (1986). Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J. Clin. Invest, 78, 1097
Malluche H. H., Faugere M.-C., Smith A. J. and Friedler R. M. (1986). Aluminium intoxication of bone in renal failure - fact or fiction? Kidney Int., 29(Suppl. 18), 70
Malluche H. H. and Faugere M.-C. (1986). Atlas of Mineralized Bone Histology. Basel: Karger
Malluche H. H. and Faugere M.-C. (1989). Renal osteodystrophy. N. Engl. J. Med., 321, 317
Malluche H. H., Ritz E. and Lange H. P. (1976). Bone mass in maintenance haemodialysis. Prospective study with sequential biopsies. Eur. J. Clin. Invest., 6, 265
Maloney N. A., Ott S., Alfrey A. C., Miller L. N., Coburg J. W. and Sherrard D. J. (1982). Histologic quantitation of aluminium in iliac bone from patients with renal failure. J. Lab. Clin. Med., 99, 206
McCarthy J. T., Hodgson S. F., Fairbanks V. F. and Moyer T. P. (1991). Clinical and histological features of iron-related bone disease in dialysis patients. Amer. J. Kidney Dis., 17, 551
McCarthy J. T. and Kumar R. (1990). Renal osteodystrophy. Endocrinol. Metabol. Clin. N. Amer, 19(1), 65
McCarthy J. T., Milliner D. S., Kurtz S. B., Johnson W. J. and Moyer T. P. (1986). Interpretation of serum aluminium values in dialysis patients. Amer. J. Clin. Pathol, 86, 629
Meyer J. L. and Thomas W. C. (1986). Aluminium and aluminium complexes. Effect of calcium phosphate precipitation. Kidney Int., 29(Suppl. 18), 20
Norfray J., Calenoff L., DelGreco F. and Krumlovsky F. A. (1975). Renal osteodystrophy in patients on hemodialysis as reflected in the bony pelvis. Amer. J. Roentgenol., 125, 352
Norris K. C., Goodman W. G. and Howard N. (1986). The iliac crest bone biopsy for the diagnosis of aluminium toxicity and a guide to the use of deferoxamine. Semin. Nephrol., 6(Suppl. 1), 27
Parisien M., Charhon S.A., Arlot M., Mainetti E., Chavassieux P., Chapuy M.-C. and Meunier P. J. (1988). Evidence for a toxic effect of aluminium on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease. J. Bone Miner. Res., 3(3), 259
Quarles L. D., Dennis V. W. and Gitelman H. J. (1984). Aluminium deposition in bone: an epiphenomenon of the osteomalacic state. Clin. Res., 32, 522
Revell P. A. (1986). Pathology of Bone Berlin: Springer
Ritz E., Krempien B., Mehls O. and Malluche H. H. (1973). Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int., 4, 116
Russell J. E., Avioli L. V. and Mechanic G. (1975). The nature of the collagen cross-links in bone in the chronic uraemic state. Biochem. J., 145, 119
Russell J. E., Termine J. D. and Avioli L. V. (1973). Abnormal bone mineral maturation in the, chronic uremic state. J. Clin. Invest, 52, 2848
Sherrard D. J. (1991). Aluminium - much ado about something. N. Engl. J. Med., 324, 558
Shusterman N. H., Wasserstein A. G., Morrison G., Audet P., Fallon, M. D. and Kaplan F. (1987). Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis. Amer. J. Med., 82, 1148
Slatoplsky E. (1987). The interaction of parathyroid hormone and aluminium in renal osteodystrophy. Kidney Int., 31, 842
Slatopolsky E. and Coburn J. W. (1990). Renal osteodystrophy. Avioli L. V. and Krane S. M., Metabolic Bone Disease (p. 452). Philadelphia: Saunders
Steiniche T., Mosekilde L., Christensen M. S. and Melsen F. (1989). A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalcuria. Acta Pathol. Microbiol Immunot Scand., 97, 309
Stewart P. J., Green O. C. and Stern P. H. (1986). Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro. J. Bone Miner. Res., 1, 285
VandeVyer F. L., Visser W. J., Haese P. C. and DeBroe M. E. (1990). Iron overload and bone disease in chronic dialysis patients. Nephrol. Dial. Transplant., 5, 781
Wills M. R. and Savory J. (1983). Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet, 2, 29
References added in proof
Coe F. L., Parks J. H. and Asplin J. R. (1992). The pathogenesis and treatment of kidney stones. N. Engl. J. Med., 327, 1141
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1993 R. Bartl and B. Frisch
About this chapter
Cite this chapter
Bartl, R., Frisch, B. (1993). Renal bone disease. In: Biopsy of Bone in Internal Medicine: An Atlas and Sourcebook. Current Histopathology, vol 21. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2222-1_14
Download citation
DOI: https://doi.org/10.1007/978-94-011-2222-1_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4985-6
Online ISBN: 978-94-011-2222-1
eBook Packages: Springer Book Archive